Korean Journal of Biological Psychiatry

At the beginning, researches on the biology of depression or affective illness have focused mainly on the receptor functions and neuroendocrine activities. And the studies of the past years did not break new theoretical background, but the recent advances in the research on the molecular mechanisms underlying neural communication and signal transduction do add some insights to many established ideas. This article will overview some of the more recent advances in the clinical researches of depression. Our major concerns to be presented here include the followings：(1) alterations in the post-synaptic neural transduction；(2) changes in the neurons of hypothalamic neuropeptides；(3) decreased peptidase enzyme activities；(4) associations of hypothalamic-pituitary-adrenal axis abnormalities with serotonin neurotransmission；(5) role of serotonin transporter；(6) changes in the responsiveness of intracellular calcium ion levels；(7) the inositol deficiency theory of lithium and depression；(8) the transcription factors including immediate early genes；(9) recent genetic studies in some families. This brief overview will suggest that changes in DNA occur during antidepressant therapy. These changes at the DNA level initiating a cascade of events underlying antidepressant modality will give us the insights on the molecular biological basis of the pathogenesis of depression and cues for a new class of antidepressants.

Keywords Depression;Neurobiology;Serotonin;Neuropeptide;Enzyme.